Introduction and background
Prostate cancer is a major health problem, second only to nonmelanoma skin cancer as the most common cancer in men in the United States. Furthermore, the rate of prostate cancer is higher and the mean age-of-onset is younger in African Americans than in non-African Americans [1] [2] [3] . Prostate cancer prevention trials (PCPTs) provide an important opportunity to test interventions that might reduce the burden of the disease [4] . However, unambiguous application of the results of such trials to African Americans depends upon adequate participation by African American men.
The PCPT was the first large, cooperative group randomized trial for the prevention of prostate cancer in healthy men [5] . The randomized participant goal for African American men was set at 8% to mirror the estimate of African American men aged 55 years in the US population. Only 4% African American men were randomized to PCPT during the 3-year enrollment period. Efforts to enhance minority participation in PCPT were not initiated until 1 year after the study was activated. In addition, about two-thirds of the overall accrual goal was met in the first year of recruitment, so any enhanced African American enrollment after that time could have had only a modest overall effect.
The PCPT minority recruitment experience suggested that successful recruitment of African American men into a PCPT requires recruitment efforts to be initiated at trial activation, infrastructure provided to support minority recruitment and a long-term commitment from funding agencies [6] [7] [8] . Known barriers commonly cited to impede minority recruitment must also be addressed, such as the attitudes, knowledge, and beliefs of potential minority recruits and their referring clinicians, as well as trial designs and costs [9] [10] [11] [12] [13] [14] [15] [16] [17] .
Minority recruitment lessons learned from PCPT were applied to Selenium and Vitamin E Cancer Prevention Trial (SELECT), the next large, cooperative group prostate cancer prevention study. SELECT was designed to evaluate the effect of selenium and vitamin E on the incidence of prostate cancer without changing the clinician's practice of prostate cancer screening. The SELECT overall randomization goal was 32,400 healthy men, with 6480 men enrolled every year for 5 years. The study had a pre-established goal of 24% overall minority representation: 20% African American, 3% Hispanic, and 1% Asian/Pacific Islander [18] .
Prior to trial initiation, SELECT took several steps to enhance recruitment of African American and other racial/ethnic minorities. First, the eligibility criteria were expanded. Second, sites with prior success in minority recruitment were sought, and the Department of Veteran Affairs Cooperative Studies Program was included as a SELECT affiliate because of its strong track record in minority recruitment [19] . Third, SELECT developed a national infrastructure to support minority recruitment. Fourth, SELECT provided additional funds in the form of Minority Recruitment Enhancement Grants (MREGs) to sites with the potential to increase minority enrollment [20] .
Five months after study activation, SELECT was enrolling participants at nearly twice the planned rate. Although Hispanic and Asian/Pacific Islander recruitment met or exceeded the targeted enrollment rates, while African American recruitment was much lower than anticipated, it appeared that the overall enrollment goal would be achieved in less than the planned 5 years. SELECT investigators had to respond quickly to boost African American participation. Due to the projected shortened recruitment period, a targeted yet flexible intervention was needed to increase African American participation.
Two MREG requests for applications were distributed during the accrual period. The MREG was a $50,000 site grant, provided by the National Cancer Institute and designed to increase minority enrollment by enhancing recruitment strategies at sites with the potential to increase minority recruitment. An additional purpose of the MREG was to document the success of recruitment strategies used by sites for the benefit of future studies. While all SELECT sites could apply for an MREG, applicant sites were required to demonstrate the ability to recruit minorities and/or provide evidence of access to large numbers of minority men. The MREG requests for applications focused on all minority recruitment, but applications were scored higher if African Americans were the targeted population. Sites were notified of awards within 1-3 months following receipt of their application.
The National Cancer Institute provided funding to SELECT for 11 MREGs that were awarded in mid-2002. Only 32 sites out of all 427 SELECT sites applied, fewer than, had been anticipated. At the time of this initial funding, total recruitment was 10,500 and African American participation was at 9.8%. One year later, when overall SELECT enrollment reached 20,000 and African American participation was 12.4%, the National Cancer Institute allocated additional funding to issue another request for applications. As a result of this second round of competition in mid-2003, seven existing MREG sites and four new sites were awarded MREGs. In summary, 15 SELECT sites received a combined $1.1 million in grants over 2 years to increase African American and other minority participation (Table 1 ).
Recruitment for SELECT ended in June 2004, 9 months after the last site received notification of a 2003 MREG award. SELECT accrued 35,533 participants, of whom 14.9% were African American. Although African American enrollment was less than the 20% goal, it was three times that seen in PCPT and the largest percentage of African Americans ever accrued to a cancer prevention trial.
This article describes the rationale, context, and criteria for the selection of sites that received additional funding to enhance African American accrual in the SELECT, a prostate cancer prevention study. The changes in African American recruitment at these sites compared with similar, nonawarded sites were evaluated in a quasi-experimental, post hoc analysis. Descriptions of how sites used these funds and what benefits and limitations these sites reported are also presented.
Methods

Quantitative study design
To determine whether MREG funding impacted African American enrollment in SELECT, the change in African American accrual rates before and after sites received funding was evaluated by comparing MREG sites with similar non-MREG sites in a post hoc analysis. In this quasi-experimental study design, the intervention (MREG) was not randomly assigned. The number and percentage of African American participants accrued before and after MREG sites received funding was measured.
Comparisons are presented as the change in accrual rates and odds ratios for African American versus non-African American recruitment. For the purposes of this analysis, a participant's race was determined by self-report at randomization and was recorded for SELECT in compliance with current National Cancer Institute standards. If a participant self-reported as African American, regardless of other race affiliations or ethnicity, he was considered African American.
MREG sites were frequency matched to a set of non-MREG sites with similar early enrollment patterns to obtain a comparison group of sites with similar potential for African American accrual. The matching process involved consideration of two factors. The rate at which the sites were already randomizing African American participants to SELECT early in the enrollment period (prior to receipt of any MREG funds) was a strong potential confounder. Therefore, the primary matching factor was based on the percentage of African American participants accrued as of May 31, 2002, prior to receipt of MREG funding at any site. The total number of recruits prior to May 31, 2002, was the second factor in choosing comparison sites. An exception is Site 15, which started randomizing participants after May 31, 2002; total and percentage African American accrual as of June 30, 2003, was used instead. Each comparison site was assigned a hypothetical funding date based on the date the similar, matched, MREG site received an MREG award. This site-specific date separated the pre-and post-funding periods for purposes of the analyses. A summary of MREG and comparison site characteristics is shown in Table 2 . As a whole, the MREG and comparison sites had similar characteristics. Each group included Academic Centers, VA Cooperative Study sites, Community Clinical Oncology Program sites, and Cancer Programs. There were no Community Health Centers among the comparison sites and no private practices among the MREG sites. Most sites in both groups had pre-existing foundations for accruing African Americans and had never used non-MREG SELECT resources to recruit African American participants to SELECT ( Table 2) .
Quantitative analysis
The outcomes of interest are (1) the accrual rate of African Americans, that is, the number of African Americans enrolled per month and (2) the probability that a randomized participant is African American. Although the event of interest (whether the participant randomized is African American) occurs at the participant level within each site, MREG is an intervention applied at the site level, giving rise to clustered data. Mixed effects regression models were used with the individual as the primary unit of analysis and site-specific random effects were used to account for the correlation between participants accrued to the same site.
For the tabular data presentation, the number of participants accrued per month was the total enrollment at a site for the time period, pre-or post-funding, divided by the number of months the site had been accruing participants within the specified time period (Table 3 ). Percentage African American accrual was determined by the number of African Americans accrued divided by the total number of participants accrued, for each time period per site. Mean number of participants was the sum of the monthly number of participants accrued by each site divided by 15. Mean percentage African American accrual was calculated in the same fashion, to give an approximate average effect size across sites by giving each site equal weight.
All analyses were performed using PROC NLMIXED in SAS 9.1 (SAS Institute Inc, Cary, North Carolina). To predict the number of African American participants accrued per month, the number of African Americans recruited during the entire pre-or post-funding period was used as the response and a mixed effects model assuming a Poisson distribution was fitted. The response was modeled employing a log link function and included an offset for number of months of enrollment. To estimate the odds of randomizing African American participants, a mixed effects model was used to predict the probability that a randomized participant was African American in the pre-or post-funding time periods, using a Bernoulli distribution with a logit link function. Both models included fixed effects for MREG status, time (pre-or post-funding), and an interaction term for time and MREG status. Although these were not matched analyses, the frequency matched factors were included in the models: the percentage of African American participants and number of participants accrued through May 2002. The models included random site effects for pre-and post-funding, assumed to be normally distributed with mean 0 with an unstructured covariance matrix. A test of the interaction term was conducted to determine if the change in African American accrual patterns from pre-to post-funding were different when comparing the MREG sites with the comparison sites.
The expected number of participants accrued to MREG sites in the absence of MREG funding during the post-funding period was estimated using parameters from the Poisson model by setting the MREG term to 0. The difference between this estimate and the actual African American enrollment post-funding at MREG sites provides an approximation of the additional number of African American participants accrued due to MREG funding.
Qualitative analyses
All MREG sites were required to submit monthly status reports during the period covered by MREG funding. These reports included whether or not specified minority recruitment strategies were successful. A successful strategy was defined for the sites as one that resulted in at least one randomization at a site in a given month, and an unsuccessful strategy was defined as one that had been used by the site but resulted in no randomizations that month. Successful and unsuccessful strategies were ranked by the number of times sites reported them.
In an effort to assess the overall impact of the MREG on randomizations and how the process could be enhanced, the 11 sites receiving the second round of MREG funding were asked to complete a final MREG summary report. The survey was comprised of four open-ended questions and one Likert item. These items were designed to probe the sites' experience with the MREG process by identifying institutional barriers to efficient use of MREG funds; evaluating the effectiveness of time spent on MREG-related activities; capturing lessons learned from the MREG experience; and providing an opportunity to present any relevant but previously unsolicited information.
Results
Quantitative findings
In general, overall enrollment for the 15 MREG and 15 comparison sites was steady throughout most of the recruitment period. The MREG sites enrolled 4507 total participants including 1266 (28%) African Americans; the comparison sites accrued 4025 participants of which 911 (23%) were African Americans. The rate of African American accrual for the MREG sites increased more than the comparison sites near the end of recruitment (Figure 1) .
Monthly accrual data for the MREG and comparison sites are presented in Table 3 . To allow for an evaluation of the enrollment differences between MREG and comparison sites, monthly randomization data are presented for African American and all participants by site, using means to provide an estimate of the average effect size across sites. MREG and similar comparison sites are presented side-by-side to best demonstrate the similarity of their baseline African American recruitment percentages. Other than the matched comparison site for MREG Site 11, these percentages can be seen to compare quite closely. Mean monthly African American accrual for MREG sites increased from 2.4 to 2.9 African American participants per month, while the comparison sites experienced a decrease from 1.8 to 1.1 African American participants per month. Mean percentage African American accrual across MREG sites increased from 34% to 44%; the comparison sites increased only modestly, from 25% to 28%. The mean number of participants accrued by MREG sites increased slightly, from 8.8 to 9.1 participants per month, and the comparison sites showed a decrease, from 6.8 to 3.0 participants per month. Thus, despite a minimal increase in the percentage of African American recruits between pre-and post-funding periods among the comparison sites, the low overall recruitment at comparison sites resulted in a diminished rate of African American recruitment per month.
Based on the results from the Poisson regression model, there was no evidence of a change in the monthly number of African Americans accrued to MREG sites post-funding (rate ratio ¼ 1.28 p ¼ 0.84 95% CI: 0.47-3.51). The number of African Americans randomized to the comparison sites per month decreased overall by a factor of 0.38 (p ¼ 0.003 95% CI: 0.21-0.69) in the post-funding time period. The change in monthly African American accrual rate for MREG sites is 3.38 times the monthly change in accrual rate for comparison sites (p ¼ 0.004 95% CI: 1.51-7.57). This ratio indicates that while the MREG sites maintained the same levels of African American enrollment, the comparison sites' rates of enrollment of African Americans declined.
Results from the Bernoulli regression model showed the proportion of African American participants at the MREG sites increased after the receipt of funding. The odds for African American enrollment post-funding was 1.99 (p ¼ 0.08 95% CI: 0.91-4.32) times the odds pre-funding. In contrast at the comparison sites, the proportion of African American accrued did not increase (OR ¼ 1.07 p ¼ 0.77 95% CI: 0.68-1.69).
Comparing changes for MREG to non-MREG sites, the relative odds ratio was 1.86 (p ¼ 0.048 95% CI: 1.01-3.43), demonstrating that the MREG sites increased their odds of accruing African American participants post-versus pre-funding while the comparison sites did not.
MREG sites accrued 850 African American participants after receiving MREG funding. Based on the Poisson model parameters, the expected number of African American participants these sites would have accrued in the absence of MREG funding is 248. The difference between these values, 602, is the approximate additional number of African American participants accrued at MREG sites due to MREG funding.
Qualitative findings
All MREG sites submitted monthly reports including minority recruitment strategies attempted during the funding period. Recruitment strategies that most frequently resulted in randomizations included: (1) additional staff time; (2) providing resources such as transportation and parking support, minority recruitment materials, and refreshments for recruitment meetings; (3) recruiting through the media; (4) mass mailings; and (5) prostate cancer screening clinics during off-hours. Strategies that were reported to result in very few randomizations and which some sites rated as unsuccessful included: (1) publicizing SELECT at health fairs, churches, barbershops, laundromats, and grocery stores; (2) local spokespersons; and (3) networking with clinics and community leaders. Some participants were recruited by affiliation with PCPT. The following three unsuccessful strategies included: (1) publicizing SELECT as a link on a local website, (2) targeting women's groups, and (3) publicizing the National Cancer Institute's website for cancer prevention information.
Eight of 11 eligible sites completed final MREG summary reports at the end of the second MREG funding cycle. Of these sites, 88% rated the time they spent on MREG-related activities as 'effective' or 'very effective'. Eighty-eight percentage of these sites also recommended that future studies provide additional funding to enhance African American recruitment before trial activation. The most common benefits listed by these sites included extra staff time (including evenings and weekends) to focus on African American recruitment and assist with planning, outreach, and hosting activities and funds for advertising and mass mailings. All sites reported hiring additional staff, usually a minority outreach coordinator, and most sites increased existing staff time for minority recruitment. Other activities supported by the MREG included transportation and parking support, minority recruitment materials, recruitment advertisements in local media, food and supplies for recruitment meetings and postage for mass mailings. MREG sites reported barriers that included funding and staffing delays, the absence of staff during summer vacation season when the first MREG became available, minority recruiter illness, and possible participant distrust of clinical trials. Some sites reported that it took additional staff time to recruit African American men. Sites also reported screening men who were not enrolled because they lived outside any SELECT study site area or they were African American men old enough for prostate screening but too young to qualify for SELECT.
Similar information on strategies used to enhance African American recruitment was not requested from the 15 comparison sites. Hence, it was not possible to determine whether the strategies reported by MREG sites, or their purported successes or failures, were similar or different from those possibly employed by comparison sites.
Discussion
We have presented qualitative and quantitative data that explore the impact of MREGs on African American recruitment in the SELECT, a large, multisite prostate cancer prevention study. Although SELECT did not meet the target of 20% for African American enrollment, the MREG sites contributed to an increase in African American randomizations. When compared to 15 sites that did not apply for or receive MREG funding, matched in a post hoc, quasi-experimental design, MREG sites had statistically significant increases in African Americans accrued per month and higher odds of accruing African American participants when comparing post-versus pre-funding periods. Both differences are statistically significant, indicating the MREG sites were successful in increasing African American randomizations after receiving the grants.
In this quasi-experimental analysis, the choice of comparison sites imparts an important limitation to these findings. The comparison sites had not applied for MREG funding, and there are no measures of their actual potential and motivation for either maintaining or expanding African American recruitment in the latter stages of SELECT recruitment. If a different mix of comparison sites had been chosen on a primary factor other than on pre-funding frequency of African American recruitment, differences in African American recruitment rates between MREG and non-MREG sites might have been more or less pronounced. Another limitation is that the amount of funding each site received was not considered, only the event of ever having received MREG funding.
A cost effectiveness analysis of this intervention was not conducted. However, it is estimated that MREG funding resulted in 602 additional African American participants. If the only outcome of importance from the MREG is African American enrollment, then the cost per additional African American participant accrued is approximately $1827, contrasted to the $1000 SELECT paid to the sites for each randomization. The intervention was expensive but effective.
Simply providing an additional $827 to SELECT sites for each African American man randomized may have increased the number of African American men enrolled to SELECT but probably would not have increased the overall recruitment of men to SELECT as seen with the MREG awards. Additionally, some sites would not have the access or resources to recruit from the African American population, regardless of the financial incentive to do so.
There were other potential benefits to the sites who received these grants that are unmeasured but important to the conduct of SELECT and future trials. These potential benefits could include: increasing overall randomizations by MREG sites; gaining a greater presence and support in the targeted communities; providing health education and clinical trials information to the community; and increasing a recruitment base for future studies.
The impact of the MREG on African American and total recruitment varied among the funded sites. Although these sites were chosen for their ability to recruit African American participants, not all MREG sites increased African American randomizations. For example, Site 12 was unable to hire a minority recruiter as planned, which contributed to their decrease in overall and African American enrollment after receipt of MREG funding. Some sites, such as Site 15, with high initial African American randomizations, used the funds to increase their overall enrollment rates while maintaining that of African Americans. Site 4 had a decline in overall enrollment rates just prior to receipt of MREG funding. They reported that their existing financial resources were being depleted, that the current staff was unable to handle additional volume, and that they were unable to continue their recruitment efforts at the same level in the absence of assistance. Had the MREG not been available, Site 4 would probably have made a reduced contribution to African American participation. Additionally, Site 7, the largest MREG site, improved only Hispanic recruitment after receiving MREG funding, even though its stated intent was to increase both Hispanic and African American participation.
There are several potential sources of bias for this study. First, the intervention sites were not randomly selected, but were chosen via an application process where they had to demonstrate the potential and ability to recruit African American participants to SELECT. Some sites may have had existing minority recruitment programs in place; other sites may have been initiating African American recruitment efforts. Sites may have been experiencing a decrease in randomizations, such that MREG funding allowed them to continue African American enrollment at their preliminary rate, rather than increasing accrual; other sites may have been able to use funds to boost existing African American randomizations.
Varying degrees of success and failure were seen with some strategies, including publicizing SELECT at health fairs, networking with clinics, working with community leaders, and recruiting through churches. These variations speak to site and community differences and the intricacies of recruitment methodologies. Although we recommend the successful strategies used in SELECT, we realize that one size does not fit all, and sites need to have flexibility as to which strategies they pursue.
Although application for the first MREG award was open to all SELECT sites, only 32 SELECT sites (<10%) responded to the first request for applications. MREG funding was implemented after the trial was open and when sites were actively enrolling participants, overall at a higher than anticipated rate. This early success in overall accrual may have contributed to the fewer than expected number of sites applying for an MREG. Most sites would have established staff assignments to SELECT and budgeted funds and time commitments prior to the first MREG announcement. These site staff may have perceived that their site infrastructure and accrual goals could not accommodate the additional work involved in enhancing minority recruitment. Site staff may not have believed that they were able to increase minority enrollment to SELECT even with additional funding due to lack of access to the African American population or workload issues. A number of sites experienced delays in gaining access to MREG funds due to impediments within their own institutions. This resulted in further hiring and implementation delays. These factors lend further support for initiating minority recruitment strategies at trial inception and implementing them at the onset of randomization.
National African American minority recruitment strategies promoting prostate screening and SELECT may have augmented African American accrual for both MREG and non-MREG sites. For example, all sites were strongly encouraged to enroll African American men to SELECT, not just MREG sites. Three minority accrual workshops were conducted to increase African American enrollment to SELECT. The participating sites included both MREG and non-MREG sites with the potential to enhance African American recruitment. These workshops provided a forum for sites to exchange ideas form mentoring relationships and discuss strategies. Other nationwide minority recruitment strategies included 'SELECT Sunday', a faith-based strategy initiated in November 2003; African American media personalities participated in limited media spots promoting SELECT; and a barbershop initiative that preceded the release of the movie Barbershop 2, which opened February 6, 2004. Annual events surrounding Prostate Cancer Awareness Month, Minority Cancer Awareness Week, and Fathers Day also had the potential to boost enrollment to SELECT, and some sites tailored these events to enhance African American recruitment.
Future researchers considering the use of targeted funding to boost minority participation are recommended to make funds available and plan minority recruitment strategies prior to trial activation. A study should be ready to implement strategies before recruitment opens, choose recipient sites wisely, minimize delays incurred with hiring additional staff, and allow flexibility in the use of funds so sites can tailor interventions to their own needs. The information and strategies presented here should help guide future large-scale prevention and treatment studies, where recruitment of sufficient numbers of African American participants is necessary ethically and as a practical means to generalize results to this population.
